Lipid composition is expected to play an important role in modulating membrane enzyme activity, in particular if the substrates are themselves lipid molecules. A paradigmatic case is fatty acid amide hydrolase (FAAH), a critical enzyme in terminating the endocannabinoid signalling and an important therapeutic target. Here, using a combined experimental and computational approach, we show that membrane lipids modulate structure, subcellular localization and activity of FAAH. We report that FAAH dimer is stabilized by the lipid bilayer and shows higher membrane binding affinity and enzymatic activity within membranes containing both cholesterol and the natural FAAH substrate, anandamide (AEA). Additionally, colocalization of cholesterol, AEA, and FAAH in mouse neuroblastoma cells suggests a mechanism through which cholesterol increases the substrate accessibility of FAAH.
INTRODUCTION
because they form micellar structures with a volume several times larger than that of FAAH, thus completely masking the scattering signal of the protein.
Membrane binding measurements
Fluorescence spectra were recorded at 25°C using a Perkin Elmer LSB50 fluorimeter (PerkinElmer Life and Analytical Sciences, Boston, MA, USA) and 10x2 mm pathlength quartz fluorescence microcuvettes (Hellma, Plainview, NY, USA). Pyrene-liposomes used in fluorescence resonance energy transfer (FRET) studies contained 5% (w/w) 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-1-pyrenesulfonyl (Py-PE), that was purchased from Molecular Probes (Eugene, OR, USA). FAAH was used at a final concentration of 0.2 M, while liposome concentration varied between 10 and 600 M in a final volume of 100 l. Using these diluted protein samples, both in the presence or in the absence of 0.1 M NaCl, aggregates and differences in the membrane binding properties of FAAH were not observed (data not shown). Solutions containing freshly prepared FAAH and Py-PE liposomes were used in all experiments. Emission spectra ( ex = 292 nm, and  em = 300-420 nm) were recorded in lysis buffer without trehalose. Data were plotted as fractional loss of Trp fluorescence (F/F max ) versus liposome concentration, as previously described [24] . Experimental data were analyzed by nonlinear regression through an hyperbolic binding isotherm, using the Kaleidagraph program (Synergy Software, Reading, PA, USA). Large unilamellar vesicles (LUVs) were prepared with POPC, as previously described [24] . LUVs containing lipid rafts (indicated as lipid rafts) were prepared with DOPC, brain sphingomyelin, and cholesterol in an equimolar ratio (1:1:1), as reported [25] . Cholesterol-and AEA-enriched LUVs were prepared using POPC, AEA, and cholesterol at molar ratios from 10:1:1 to 10:1:5. The same vesicles were prepared also with PEA, SEA, AA, and ethanolamine instead of (and at the same molar ratio as) AEA. Cell membranes isolation and characterization PM and RE membranes were isolated from rat liver as previously reported [26] with some modifications. Briefly, the hepatic tissue was disrupted using a Potter glass, and mixed with an equal volume of disruption buffer (5 mM Tris/HCl pH 7.8, containing 10 mM KCl and 5 mM EDTA, HB). After centrifugation at 2,000 g for 5 min the supernatant was transferred to a 12 mL ultracentrifugation tube, and was sequentially overlaid with 9.6 mL of 60 % sucrose buffer, 4.5 ml of 37 % sucrose buffer, and Top solution (1 ml of HB) followed by centrifugation at 150 000 g for 2 h. In the last step the PM and the membrane of the ER was recovered with a glass Pasteur pipette, washed with the HB buffer and then centrifuged for 1 h at 150,000 g. The final pellet was dried for 12 h in an essicator and stored at -20°C until use. The analysis of phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylcloline (PC) and sphingomyelin (SM) in PM and ER extracted from liver was carried out by HPLC in a Luna Silica Column 3mm, 150x4.6 mm (Phenomenex Inc., Torrance, CA, USA), using acetonitrile-methanol-85% phosphoric acid (100:10:0.8, V/V) as mobile phase (flow rate 1ml/min) and an UV detector set at 205 nm (Perkin Elmer Inc., Waltham, MA, USA). Quantitative analysis was performed by the external standard method for each of the investigated lipids; the calibration linear range was 0.010-2.000 mg/ml. PM and ER extracts were dissolved in chloroform and injected in the HPLC system without further treatment. Identification of the compound was based on retention time. Cholesterol quantification was obtained with the same chromatographic column using hexaneisopropanol (99:1, V/V) as mobile phase (flow rate 0.6 ml/min) and an UV detector set at 202 nm. The calibration linear range was 0.005-1.500 mg/ml, sample extracts were dissolved in chloroform and injected in the HPLC system. Imaging and co-localization analysis All experiments were carried out on a Leica TCS SP5 DMI6000 confocal microscope (Leica Microsystems, Wetzlar, Germany). Details of cell culture, treatment and staining are reported in the Supplementary Methods. For co-localization analysis, we determined the Pearson's correlation A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law. coefficient and the intensity correlation quotient, by using the ImageJ plugin JACoP that groups together the most important co-localization tools [27] . Values for Pearson's correlation coefficient can range from +1 to -1: +1 represents a perfect correlation, -1 represents a perfect exclusion, and 0 represents a random localization [28] . In addition, apparent co-localization due to random staining, or very high intensity, in one window will have values of intensity correlation quotient near to zero, while if the two signal intensities are interdependent (co-localized) these values will be positive with a maximum of 0.5 [29] . Statistical analysis Data reported in this paper are the mean (± S.D.) of at least four independent determinations, each performed in triplicate. Statistical analysis was performed by the non-parametric Mann-Whitney U test, analyzing experimental data by means of the Prism 5 program (GraphPAD Software for Science, San Diego, CA, USA).
Molecular dynamics simulations
All molecular dynamics simulations were performed using ACEMD [30] locally and on the GPUGRID.net distributed computing network [31] . All simulations were all-atom, explicit solvent simulations using TIP3P water. The CHARMM 27 force field [32] was used for the protein; CHARMM Lipid C36 parameters [33] were used for POPC and cholesterol; AEA was parameterized with the CGenFF forcefield and the ParamChem web service [34] . The protein structure was taken from Protein Data Bank (PDB) ID 1MT5, but with the MAFP inhibitor removed. CHARMM-GUI [35] was used to build membrane components. Details about setup, equilibration, and production runs of all simulations are reported in the Supplementary information.
RESULTS

FAAH structure is modulated by membranes
The truncated form of rat FAAH resolved at 2.8 Å by x-ray crystallography [4] was used in this investigation, and its conformation in solution was analyzed by SAXS. As calculated from the p(r) function (and in accordance with the Guinier analysis) ( Figures 1A-1B) , SAXS data of FAAH yielded a radius of gyration of 129±13 Å, and a value of the maximum dimension of the particle (D max ) of 410±10 Å. Ab initio calculations of the shape of the molecule, performed from the SAXS pattern with the DAMMIN program [19] , indicated that FAAH has an overall structure with three lobes. Each of them is well-fitted by the crystallographic unit of the protein, that is an octamer of dimers (Supplementary Scheme 1). Indeed, superimposing the crystallographic unit of FAAH (pdb entry 1MT5.pdb) on the low resolution DAM models of the oligomers, it appears that in the absence of detergents FAAH is composed of three octamers ( Figure 1C) . Thus, the enzyme shows a peculiar topology in solution, where the crystallographic unit seems to behave as a building block for an oligomeric structure elongating along a specific axis, thus leading to an unprecedented structural organization of the enzyme ( Figure 1C ). Being FAAH a membrane enzyme stably bound to membranes in vivo, this protein oligomer is catalytically active in solution, but does not represent the bioactive conformation. Thus, in order to mimic the membrane milieu, we used detergents with a small micellar volume [36] . In the presence of 1% (W/V) Triton X-100 we obtained a scattering profile where a typical oscillation (at q values higher than 0.12 Å -1 ), due to the form factor of the detergent micellar structure, was evident ( Figure 2 ).
The Guinier analysis of this scattering curve yielded a value of the radius of gyration of 35.6±0.2 Å (Figure 2 ), very similar to the theoretical value obtained from the dimeric biological unit of the crystallographic structure [4] (Supplementary Scheme 1). Thus, in the presence of the detergent FAAH is mainly organized as a dimer, suggesting that upon interaction with membranes the oligomeric form of FAAH dissociates. Interestingly, Triton X-100 did not affect the dependence of FAAH activity on A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law. substrate concentration, that followed a typical Michaelis-Menten kinetics yielding K m , k cat and k cat /K m values of 16 ± 3 μM, 5.6 ± 0.6 s -1 , and 3.5×10 5 μM -1 s -1 , respectively, in the presence and in the absence of the detergent. Incidentally, these values are in line with those already reported for FAAH by others [2;15] . Since the dissociated FAAH dimers had the same kinetic properties as the oligomeric form of the enzyme, it can be concluded that Triton-X does not affect the catalytic activity of FAAH, and that the oligomerization state of the protein does not influence the enzyme activity.
To further understand the effect of membranes on FAAH structure and function, we analysed the intrinsic fluorescence of the enzyme in the presence of large unilamellar vesicles (LUVs) constituted by POPC. The fluorescence spectrum of FAAH is very broad, due to the presence of more than one emitting species [37] ; yet, increasing the concentration of POPC vesicles led to a relevant red-shift of the wavelength at the emission maximum (λ max from 343.5 to 346.0 nm) ( Figure 3 ). Interestingly, this effect was not replicated by simply diluting the enzyme, which suggests an overall higher exposure of the aromatic residues of the protein to the water solvent in the presence of membranes ( Figure 3) . Instead, the observed red-shift seems to be attributable to a general increase in the solvation of the protein, due to the dissociation of the octameric structure. These data indicate that the protein oligomer observed at high protein concentration used for SAXS measurements (i.e. ~ 8.0 µM, ~1.0 mg/ml) was also present ( Figure 3 ) in more diluted solutions (up to ~ 0.2 µM, i.e. ~ 0.03 mg/ml).
FAAH preferentially binds to membranes containing both AEA and cholesterol
The structural analysis was further extended by measuring the membrane binding properties of FAAH through fluorescence resonance energy transfer (FRET). To ascertain whether FAAH had any preference for specific membranes, we made LUVs of different lipid compositions. Membrane binding of FAAH was not affected by the physicochemical properties of the membrane, because half-saturation binding values ([L] 1/2 ) were similar with membranes in liquid disordered crystalline phase (POPC vesicles) and in solid-like gel phase (β-phase) (DPPC vesicles) (Table 1) . Therefore, in subsequent FRET experiments only POPC LUVs were used, being also POPC one of the most common lipid in animal cell membranes [38] . A role for cholesterol in modulating AEA movement within the membrane has been recently reported in biophysical studies [8;39] . Here, we found that the co-presence of AEA and cholesterol within POPC membranes, at a stoichiometric ratio from 1:1 to 1:5, induced a pronounced decrease of [L] 1/2 (14.7 ± 3.0); this indicates a strong increase (~5-fold over the POPC control) of the affinity of FAAH for AEA/cholesterol-containing membranes (Table 1 , and Figure 4 ).
To ascertain whether this preferential interaction could be ascribed to a general modification of the physicochemical properties of the membrane, or was rather due to the presence of a specific class of polyunsaturated lipids or functional groups, we tested also the effect of AEA hydrolysis products (arachidonic acid (AA), and ethanolamine), and of other fatty acid amides, such as Nstearoylethanolamine (SEA) and N-palmitoylethanolamine (PEA). In all cases higher [L] 1/2 values were obtained ( Table 1 ), demonstrating that the preferential binding of FAAH occurred only with membranes containing AEA. As expected for a membrane enzyme associated with the ER [3] , FAAH shows a higher binding affinity for membranes in the liquid disordered state (POPC) and a weaker interaction with lipid rafts structures typical of the PM [16] . Thus, we further tested whether the preferential binding of FAAH was maintained in lipid rafts-containing membranes. Embedding AEA within lipid rafts-containing LUVs [25] did not significantly affect the binding of FAAH (Table 1 , and Figure 4 ), overall suggesting that this enzyme prefers membranes containing AEA within cholesterol-rich regions in the liquid disordered phase, rather than organized in lipid rafts. We extended these experiments further by analysing FAAH binding to PM and ER membranes isolated from rat liver, as described in Supplementary methods. These results showed that FAAH preferentially binds to ER membranes (containing ~ 3% mol/mol of cholesterol) (Supplementary Table 1 [L] 1/2 values very similar to those obtained with AEA/cholesterol-containing synthetic vesicles (Table  1 , and Figure 4 ). It should be recalled that ER membranes are the primary sites of accumulation of AEA (Supplementary Figure S1) .
FAAH activity is modulated by cholesterol
To clarify whether the preferential interaction of FAAH with AEA/cholesterol-containing membranes could influence also the enzyme activity, we measured AEA hydrolysis by FAAH in the presence of different synthetic membranes. FAAH showed a similar catalytic activity in solution and when bound to POPC vesicles ( Figure 5 ). Externally adding FAAH to POPC vesicles that contained increasing AEA/cholesterol molar ratios (from 1:1 to 1:5), an increased enzyme activity up to ~4-fold over the controls was observed (Figure 5 ), indicating that FAAH activity can be modulated by the co-presence of cholesterol and AEA within the membrane in a cholesterol concentration-dependent manner ( Figure  5 ). This effect can be explained by the increased affinity of FAAH for membranes containing both AEA and cholesterol (Table 1) , leading to higher amounts of membrane-embedded enzyme with respect to the control. Incidentally, the cholesterol/POPC ratio did not affect the specific activity of FAAH.
FAAH colocalizes with AEA and cholesterol in mouse neuroblastoma cells
Fluorescence microscopy analysis of mouse N18 neuroblastoma cells revealed that FAAH is distributed in several dotted structures widely diffused in the cytoplasm, and particularly prominent in the perinuclear zone ( Figure 6 ). These findings extend previous studies showing that FAAH is primarily associated with membranes of the ER, and excluded from the PM [40] . To compare the degree of association of FAAH with different lipids and/or membrane compartments, a series of costaining experiments was performed with specific lipid markers: biotinil-AEA (b-AEA), a stable analogue of AEA, was used to stain ER and adiposomes [41]; filipin, a fluorescent macrolide that specifically binds to both raft and non-raft membrane cholesterol, was used to stain free cholesterol [9]; Alexa Fluor 555-conjugated cholera toxin B (CTB) was used to stain ganglioside GM1, a lipid selectively confined to lipid rafts [9] . The extent of spatial overlap among FAAH and these lipids was measured using the Pearson's correlation coefficient, a widely accepted parameter to quantify the degree of colocalization between fluorophores [41]. A strong association between b-AEA and FAAH was found in N18 cells, with a higher colocalization between filipin-stained cholesterol and AEA, and a smaller (yet significant) association between filipin and FAAH ( Figure 6 ). In contrast, FAAH staining did not significantly overlap with that of CTB (Figure 6 ), suggesting a lower affinity of FAAH for authentic lipid rafts. Overall, FAAH appears to be mainly localized in AEA and cholesterol containing regions of internal membranes, but not in plasma membrane lipid rafts.
Molecular dynamics simulation of FAAH within the membrane
The change in the catalytic activity of FAAH in the presence of cholesterol suggests a plausible entry pathway for AEA from the lipid bilayer. Indeed, a 200 ns long molecular dynamics (MD) simulation of FAAH embedded in the membrane showed that the protein relaxes to a pose similar to what already presented in the literature [4] , with the accessible entry of the AEA binding pocket at the interface between the polar head of the membrane and the solvent. Such a pose is compatible with the entry pathway of AEA into the binding cavity from the membrane.
In order to better understand the effect of cholesterol on AEA binding to FAAH, we simulated the full event of binding of the substrate itself [42] , thus ascertaining whether a direct interaction with cholesterol may explain the preferential membrane binding and the increased catalytic activity of FAAH. We performed more than 1,500 parallel simulations of FAAH associated with a membrane containing AEA:cholesterol:POPC at 1:5:10 molar ratio, each for an average of 165 ns, totalling over 250 μs of sampling time. Of these, 1,000 simulations were free ligand binding simulations [42] , in which 26 binding events were seen. An additional 550 simulations resampled these 26 events in order to improve binding analysis and to clarify how AEA may explore the enzyme inside. The data yielded an interesting picture of AEA binding to FAAH ( Figure 7 , and Supplementary Video 1), suggestive of a specific role for cholesterol in the modulation of the enzyme activity. AEA approached FAAH at the previously proposed membrane port [4] , exploring the pocket formed by helices α17, α18, α19 and the loop between sheet β9 and helix α22 (Figure 7-C1) . The primary barriers to entry were steric hindrance by side chains and a salt bridge formed between those secondary structure elements. Once these barriers were overcome, the polar head group of AEA moved into the enzyme, where it formed weak and transient hydrogen bonds with water and the backbone of helix α9 and helix α22, as well as with the loop preceding it (Figure 7-C2) . AEA then displaced more water from the enzyme and moved further up into the enzyme (Figure 7-C3) , at which point the primary barrier was the highly disordered internal structure of the enzyme (in particular the very large loop between sheet β3 and helix α8), as well as further AEA dehydration. Finally, AEA took a similar pose to that shown for the MAFP inhibitor in the crystal structure (Figure 7-C4) .
The most significant outcome of MD simulations was the possible explanation of the role of cholesterol in increasing AEA binding. When the salt bridge is intact, it closes the enzyme gate and AEA is prevented from entering. The continued interaction with the cholesterol head group helps to maintain the port open while AEA enters, and allows other side chains to take conformations that make AEA binding easier. Cholesterol remains close to the enzyme even after AEA has fully entered, continuing to interact with the residues that keep the port open and fitting snugly against the enzyme in the region where AEA was before entering. In membranes made of AEA:POPC only, the probability that another lipid (e.g., another AEA) donates a hydroxyl group for the same purpose would be significantly lower. Overall, MD simulations seem to explain the role of cholesterol in increasing FAAH activity, as measured experimentally ( Figure 5 ).
The exit of the AEA cleavage reaction products (i.e., ethanolamine and arachidonic acid) is unlikely to be strongly modulated by cholesterol, while a role could also be played by increased lateral diffusion of AEA in cholesterol-containing membrane domains. To address this point, diffusion coefficients were computed for AEA through MD simulations. For the AEA:POPC (9:75) and the AEA:Chol:POPC (9:45:75) systems these coefficients were found to be, respectively, 16.9 ± 5.9 and 13.6 ± 5.0 × 10 -8 cm 2 /s, with no statistically significant difference. Incidentally, these values of the diffusion coefficients are consistent with previous data obtained experimentally [43] . Next, we investigated whether the effect of cholesterol on FAAH activity could be related also to an increased interlayer (flip-flop) movement of AEA [8] , measured as cholesterol-dependent increase in the AEA flip-flop rate between bilayers. Using all atom simulations (see Supplementary Information), we did observe a qualitative higher flip-flop rate for AEA with cholesterol.
DISCUSSION
The crystallographic unit of FAAH is constituted by octamers of dimers and the derived biological unit is a dimeric protein [4] (Supplementary Scheme 1) . SAXS measurements reported here show that in solution FAAH adopts a higher hierarchical organization of its quaternary structure, constituted by three octamers of dimers (Figure 1) . Combined SAXS and fluorescence analyses show that the binding of FAAH to membranes (or to detergents that mimic the membrane milieu) induces a dissociation of these oligomers, and stabilizes the dimeric form of the enzyme. Remarkably, the dimer of FAAH is a functional unit with the same catalytic activity as the octamer. Additional FRET measurements allowed to assess the preferential interaction of FAAH with membranes containing both AEA and cholesterol, yet not organized in lipid rafts. The ~5-fold increase of FAAH affinity for membranes in the presence of cholesterol and AEA appears to be specific for AEA and not for other eCBs, and is not observed with either lipid alone. Moreover, data obtained with PM and ER membranes from rat liver are superimposable on those obtained with synthetic vesicles. In particular, considering that ER membranes contain ~3% of cholesterol and that AEA is mainly localized in this compartment (Supplementary Figure S1) , our data strongly suggest a physiological role of these lipids in maintaining the proper intracellular localization of FAAH.
By confocal analysis we revealed that FAAH is consistently confined to AEA/cholesterol-rich regions, with very low association with GM 1 -rich membrane domains on the cell surface ( Figure 6 ). Such a preferential binding of FAAH could contribute in vivo to maintain the enzyme stably localized in a compartment with more efficient hydrolysis of AEA within cell membranes containing non-raft cholesterol, such as those of ER, or those of intracellular stores of AEA like the adiposomes [26] .
FAAH mainly interacts with one leaflet of the membrane bilayer (Figure 7-A) , thus it is conceivable that AEA reaches the active site of the enzyme only from that leaflet via the so-called membrane port [4] . Cholesterol could induce a higher catalytic activity of FAAH by directly interacting with the enzyme, thus increasing the accessibility to AEA of the membrane port. Consistently, our MD studies clearly indicate that the binding of AEA is directly aided by cholesterol that is more concentrated around the membrane port of FAAH (Figure 7-B) . Through its interaction with key salt bridge residues that gate AEA entrance, cholesterol facilitates port opening, so that AEA can enter and reach the active site of the enzyme. These results support the concept of a substrate-enzyme interaction, whereby a third player comes into the game: the membrane lipids. In the case of metabolic enzymes of eCBs, these observations might have therapeutic relevance. On a more general note, this investigation sheds light on the key-role of the lipid environment in determining biological activity. This concept emerged in recent years for membrane receptors [44] , and here we show that it holds true also for a membrane enzyme like FAAH, that is at the heart of eCB signalling in many pathophysiological events [45] .
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